PerkinElmer Inc

Most Recent

  • uploads///VAR
    Company & Industry Overviews

    Here’s What Varian Medical Systems’ Valuation Trend Indicates

    Of the nine analysts covering Varian Medical Systems (VAR) stock, three have given it a “strong buy,” three have given it a “hold,” and three have given it a “sell.”

    By Kenneth Smith
  • uploads///life sciences group
    Company & Industry Overviews

    Thermo Fisher Scientific Accelerates Its Semiconductor Sequencing

    On June 29, 2017, Thermo Fisher Scientific (TMO) announced the addition of three new products to its semiconductor failure analysis workflows portfolio.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    What Bio-Rad Laboratories Expects from Life Science

    In 1Q17, Bio-Rad Laboratories’ (BIO) Life Science segment reported revenues of ~$174.3 million, which represents a YoY rise of ~5.1%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Bio-Rad Laboratories’ Profit Margin Expectations in 2017

    On March 13, 2017, Bio-Rad Laboratories (BIO) announced that it expects to reach an EBITDA margin of around 20% by 2020.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Bio-Rad Laboratories’ Robust Revenue Growth Projection for 2017

    On March 13, 2017, Bio-Rad Laboratories (BIO) provided a long-term, currency-neutral revenue growth target of around 3%–5%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Bio-Rad Laboratories on the Street: Analysts’ Recommendations in May

    In 1Q17, Bio-Rad Laboratories (BIO) reported revenues of ~$500.1 million, which represented a YoY (year-over-year) rise of around 6.1%.

    By Margaret Patrick
  • uploads///Part  Graph
    Company & Industry Overviews

    XLV’s Mid Caps Underperform SPY

    PerkinElmer went down by 3.1% to close at $48.58 and was trading just below the 20-day moving average.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    XLV Mid-Cap Stocks Witness Profit-Booking

    The mid-cap stocks of the Health Care Select Sector SPDR ETF (XLV) fell collectively by 2.6%. They underperformed XLV as of March 8, 2016.

    By Peter Neil
  • uploads///Graph Part  Dec
    Company & Industry Overviews

    Waters Led XLV’s Electronic Subgroup

    Waters closed at $133.73 and was trading above its 100-day moving average price of $126.45, and it was also trading above its 20-day moving average price of $131.44.

    By Peter Neil
  • uploads///Graph Part  Dec
    Company & Industry Overviews

    Tenet Is the Only XLV Mid-Cap Stock with Positive Returns

    With a return of 0.15%, Tenet Healthcare (THC) was the only stock among XLV’s mid caps that gave a positive return on December 9.

    By Peter Neil
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    How PerkinElmer Topped the XLV’s Mid-Cap Stocks

    At the Stifel 2015 Healthcare Conference, PerkinElmer presented its current position as well as its future growth and strategies for different markets.

    By Peter Neil
  • uploads///ISMREV
    Macroeconomic Analysis

    Service Sector Expanded at Faster Rate in October

    The service sector makes up more than 85% of the US economy. With manufacturing picking up in October, faster growth in the service sector may further ramp up economic growth.

    By Lara Sheldon
  • uploads///Graph Part
    Company & Industry Overviews

    Patterson Companies Was XLV’s Worst Performer

    Patterson Companies was the worst performer within the Health Care Select Sector SPDR ETF (XLV) for the period between August 25 and August 31, with a return of -4.10%.

    By Peter Neil
  • uploads///Graph Part
    Company & Industry Overviews

    PerkinElmer and Mallinckrodt Help Bottom Ten Stocks in XLV

    PerkinElmer (PKI) with a return of 5.94% was the best performer of XLV’s bottom ten stocks.

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.